A band of medical device, public health, and patient and consumer advocacy organizations are pressuring Congress to pass a key diagnostics reform bill in a year-end package as the deadline for funding the government looms and talks of a potential longer term continuing resolution ramp up. The bill at issue, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, would create a risk-based regulatory framework for laboratory-developed tests (LDTs) and create a user fee program for in vitro clinical tests. As...